跳至主要内容
临床试验/IRCT20160626028637N2
IRCT20160626028637N2尚未招募3 期

The effects of nano-curcumin supplementation on leptin, adiponectin gene expression and serum levels of some adipokines in obese and overweight patients with migraine.

Tehran University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Age = 20 to 50 (y)
  • 25<= Body Mass Index (kg/m2) =< 35
  • Diagnosis of episodic migraine without aura, according to IHS criteria by neurologist
  • Voluntary cooperation of patients

排除标准

  • use of dietary, vitamins and antioxidant supplements (such as curcumin) at least 4-6 weeks before the intervention
  • Following special diets or special and intense physical activity at the last 3 months before the intervention
  • Having comorbidity such as kidney disease, liver disease, pancreatitis, diabetes, cancer, thyroid disorders and inflammatory diseases, as well as patients with a history of heart attacks and strokes based on patient statements and medical history
  • Pregnancy, lactation and menopause
  • Alcohol consumption, cigarette smoking (at least 5 butts a day for the past 6 months), hookah, other types of tobacco and electronic types (VIP, anti-system)

研究者

相似试验